What would happen, if a Phase 2 is funded, but the company owning the drug candidate decides afterwards to develop the program further through Phase 3 to market (and thus does no longer comply with the 36-months-to-market dogma)?
Answer:
Not reaching this goal will most probably have negative effects for the evaluation of the FTI instrument, but there will be no penalty for the consortium.adidas
There is no other limitation than the fact that the time to market-uptake has to be no later than 3 years after the beginning of the project. So the project must not exceed 3 years. Expected are projects of 1-2 years.Men Nike Air Huarache
Although there are no formal limits in the Work Programme, you should note that in terms of impact, the expectation is that initial market take-up of the innovation should happen no later than 36 months after the start of the action.Air Jordan 1
For a proposal of an Active Pharmaceutical Ingredient (API) manufacturing method development the target is pharmaceutical industry market. Would it be applicable to FTI?